Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BARRETT BUSINESS SERVICES INCBBSI · Entity 5097 | Director | June 07, 2022 | June 09, 2022 |
| MBIA INCMBI · Entity 6171 | Director | May 12, 2026 | May 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BARRETT BUSINESS SERVICES INC
Report date June 07, 2022 · Filed June 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,475 |
Reported balance
After 2022-06-07 transaction · row 1
1 source rowRow 1 · 2022-06-07 · Exercise / conversion · Acquired 1,192 · Balance 3,475 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-07 · Grant · Disposed 1,192 · Balance 0 F1: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F2: The RSU award that was scheduled to vest on July 1, 2022, was accelerated and vested as of the conclusion of the Issuer's 2022 Annual Meeting of Stockholders on June 7, 2022, when the reporting person ceased to be a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2: The RSU award that was scheduled to vest on July 1, 2022, was accelerated and vested as of the conclusion of the Issuer's 2022 Annual Meeting of Stockholders on June 7, 2022, when the reporting person ceased to be a director.
MBIA INC
Report date May 12, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,198 |
Reported balance
After 2026-05-12 transaction · row 1
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 16,181 · Balance 121,198 F1: Restricted Stock granted on May 12, 2026 at a price of $6.18 per share with 1 year cliff vesting on May 12, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock granted on May 12, 2026 at a price of $6.18 per share with 1 year cliff vesting on May 12, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Envoy Medical, Inc.
Report date September 29, 2023 · Filed October 04, 2023
Section 16 reporting ended · disclosed 2023-10-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 25,000 |
Reported balance
After 2023-09-29 transaction · row 1
1 source rowRow 1 · 2023-09-29 · Conversion · Acquired 25,000 · Balance 25,000 F1: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. |
| Class B Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-09-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-09-29 · Conversion · Disposed 25,000 · Balance 0 F1: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2026 Filed May 13, 2026 20:12 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 16,181 | $6.18 | $99,998.58 |
DisclosureSEC source: 0000814585-26-000049 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,198 F1 · shares: Restricted Stock granted on May 12, 2026 at a price of $6.18 per share with 1 year cliff vesting on May 12, 2027. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 20:02 UTC | MBIA INC MBI · Entity 6171 | SaleCommon Stock | 4,975 | $7.15 | $35,571.25 |
DisclosureSEC source: 0000814585-25-000030 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,017 F1 · shares: The price reported in Column 4 is the share price on August 21, 2025. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold as set forth in this footnote. Read SEC document |
| May 13, 2025 Filed May 14, 2025 20:09 UTC | MBIA INC MBI · Entity 6171 | GrantCOMMON STOCK | 23,095 | $4.33 | $100,001.35 |
DisclosureSEC source: 0000814585-25-000021 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,992 F1 · shares: Restricted stock granted on May 13, 2025 at a price of $4.33 per share with 1 year vesting on May 13, 2026. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:28 UTC | MBIA INC MBI · Entity 6171 | GrantMBIA Common Stock | 16,502 | $6.06 | $100,002.12 |
DisclosureSEC source: 0000814585-24-000033 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,897 F1 · shares: Restricted stock granted on May 14, 2024 at a price of $6.06 per share with 1 year vesting on May 14, 2025. Read SEC document |
| September 29, 2023 Filed Oct 4, 2023 01:42 UTC | Envoy Medical, Inc. COCH · Entity 7161 | ConversionClass B Common Stock, par value $0.0001 per share · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018933 · form4.xml · derivative · entry 2 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock, par value $0.0001 per share · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. F1 · kind: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. F1 · price: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. F1 · derivative.exercise_date: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. F1 · derivative.expiration_date: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. Read SEC document |
| September 29, 2023 Filed Oct 4, 2023 01:42 UTC | Envoy Medical, Inc. COCH · Entity 7161 | ConversionClass A Common Stock, par value $0.0001 per share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018933 · form4.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. F1 · price: On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Ms. Dewbrey resigned as a director of Anzu. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:42 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 12,821 | $7.80 | $100,003.80 |
DisclosureSEC source: 0000814585-23-000027 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,395 F1 · shares: Restricted Stock granted on May 12, 2023 at a price of $7.80 per share with 1 year vesting on May 12, 2024. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 21:01 UTC | Envoy Medical, Inc. ANZU · Entity 7161 | OtherClass B Common Stock, par value $0.0001 per share · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-020352 · form4.xml · derivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock, par value $0.0001 per share · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). F2 · kind: On October 1, 2022, Anzu SPAC GP I LLC assigned 25,000 Class B Founder Shares to the reporting person for an aggregate consideration of $5,250. F2 · price: On October 1, 2022, Anzu SPAC GP I LLC assigned 25,000 Class B Founder Shares to the reporting person for an aggregate consideration of $5,250. F1 · derivative.exercise_date: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). F1 · derivative.expiration_date: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). F1 · derivative.underlying_shares: The shares of Class B common stock, par value $0.0001 per share (the "Class B Founder Shares") of Anzu Special Acquisition Corp I (the "Issuer") have no expiration date and (i) are convertible into shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), of the Issuer at any time at the option of the holder on a one-for-one basis and (ii) will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, in each case, subject to adjustment as described under the heading "Description of Securities-Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-252861). Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 19:44 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | GrantRestricted Stock Units · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004959 · primarydocument.xml · derivative · entry 2 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSU award that was scheduled to vest on July 1, 2022, was accelerated and vested as of the conclusion of the Issuer's 2022 Annual Meeting of Stockholders on June 7, 2022, when the reporting person ceased to be a director. F2 · derivative.expiration_date: The RSU award that was scheduled to vest on July 1, 2022, was accelerated and vested as of the conclusion of the Issuer's 2022 Annual Meeting of Stockholders on June 7, 2022, when the reporting person ceased to be a director. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 19:44 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | Exercise / conversionCommon Stock | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004959 · primarydocument.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2022 Filed May 13, 2022 21:45 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 8,361 | $11.96 | $99,997.56 |
DisclosureSEC source: 0000814585-22-000028 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,574 F1 · shares: Restricted Stock granted on May 12, 2022 at a price of $11.96 per share with 1 year vesting on May 12, 2023. Read SEC document |
| March 08, 2022 Filed Mar 8, 2022 20:12 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | PurchaseCommon Stock | 325 | $73.04 | $23,736.64 |
DisclosureSEC source: 0001562180-22-002432 · primarydocument.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,283 Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:46 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | GrantRestricted Stock Units · Derivative | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004758 · primarydocument.xml · derivative · entry 3 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,192 Underlying: Common Stock · 1,192 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in one equal annual installment beginning July 1, 2022, and will be settled by delivery of unrestricted shares of common stock on the vesting date. F3 · derivative.expiration_date: The Restricted Stock Units vest in one equal annual installment beginning July 1, 2022, and will be settled by delivery of unrestricted shares of common stock on the vesting date. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:46 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | Exercise / conversionRestricted Stock Units · Derivative | 1,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004758 · primarydocument.xml · derivative · entry 2 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in one equal annual installment beginning July 1, 2021, and will be settled by delivery of unrestricted shares of common stock on the vesting date. F2 · derivative.expiration_date: The Restricted Stock Units vest in one equal annual installment beginning July 1, 2021, and will be settled by delivery of unrestricted shares of common stock on the vesting date. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:46 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | Exercise / conversionCommon Stock | 1,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004758 · primarydocument.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:17 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 11,261 | $8.88 | $99,997.68 |
DisclosureSEC source: 0000814585-21-000029 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,213 F1 · shares: Restricted Stock granted on May 13, 2021 at a price of $8.88 per share with 1 year vesting on May 13, 2022. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:33 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | GrantRestricted Stock Units · Derivative | 1,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-005040 · primarydocument.xml · derivative · entry 3 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 Underlying: Common Stock · 1,457 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in one annual installment beginning July 1, 2021, and will be settled by delivery of unrestricted shares of common stock on the vesting date. F3 · derivative.expiration_date: The Restricted Stock Units vest in one annual installment beginning July 1, 2021, and will be settled by delivery of unrestricted shares of common stock on the vesting date. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:33 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | Exercise / conversionRestricted Stock Units · Derivative | 501 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-005040 · primarydocument.xml · derivative · entry 2 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 501 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in one annual installment beginning July 1, 2020, and will be settled by delivery of unrestricted shares of common stock on the vesting date. F2 · derivative.expiration_date: The Restricted Stock Units vest in one annual installment beginning July 1, 2020, and will be settled by delivery of unrestricted shares of common stock on the vesting date. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:33 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | Exercise / conversionCommon Stock | 501 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-005040 · primarydocument.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 16, 2020 00:38 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 15,949 | $6.27 | $100,000.23 |
DisclosureSEC source: 0000814585-20-000040 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,952 F1 · shares: Restricted stock granted on May 14, 2020 at a price of $6.27 per share with 1 year vesting on May 14, 2021. Read SEC document |
| November 04, 2019 Filed Nov 12, 2019 22:41 UTC | BARRETT BUSINESS SERVICES INC BBSI · Entity 5097 | GrantRestricted Stock Unit · Derivative | 501 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-005476 · primarydocument.xml · derivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501 Underlying: Common Stock · 501 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest in one installment on July 1, 2020, and will be settled by delivery of unrestricted shares of common stock on the vesting date. F2 · derivative.expiration_date: The Restricted Stock Units vest in one installment on July 1, 2020, and will be settled by delivery of unrestricted shares of common stock on the vesting date. Read SEC document |
| May 13, 2019 Filed May 15, 2019 19:41 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 10,917 | $9.16 | $99,999.72 |
DisclosureSEC source: 0000814585-19-000019 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,003 F1 · shares: Restricted stock granted on May 13, 2019 at a price of $9.16 per share with 1 year vesting on May 13, 2020. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 20:17 UTC | MBIA INC MBI · Entity 6171 | GrantCommon Stock | 11,086 | $0.00 | $0.00 |
DisclosureSEC source: 0000814585-18-000041 · primary_doc.xml · nonDerivative · entry 1 DEWBREY DIANE L · CIK 0001200125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,086 F1 · shares: Restricted stock granted on November 13, 2018 with a 1 year vesting provision and which will vest on November 13, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.